Chai Discovery
$3.8B
Reported valuation
OpenAI-backed; Chai-1 structure prediction and Chai-2 de novo antibody design, used by Pfizer, Lilly and Novartis.
- Founded
- 2024
- Research area
- AI for math & science — Drug discovery, Open weights
- Headquarters
- San Francisco, United States
Founders
- Jacques Boitreaud — previously Aqemia
- Jack Dent — previously Stripe
- Matthew McPartlon — previously VantAI, Absci, University of Chicago
- Joshua Meier — previously Meta (FAIR), OpenAI, Absci